Home Stock

Stock Research: COSMOS Pharmaceutical

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

COSMOS Pharmaceutical

TYO:3349 JP3298400007
13
  • Value
    58
  • Growth
    43
  • Safety
    Safety
    32
  • Combined
    16
  • Sentiment
    20
  • 360° View
    360° View
    13
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

COSMOS Pharmaceutical Corporation operates drug stores, offering medical goods, cosmetics, and general food products. In the last fiscal year, the company had a market cap of $4962 millions, profits of $1481 millions, and revenue of $7022 millions.

more

ANALYSIS: With an Obermatt 360° View of 13 (better than 13% compared with alternatives), overall professional sentiment and financial characteristics for the stock COSMOS Pharmaceutical are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for COSMOS Pharmaceutical. Only the consolidated Value Rank has an attractive rank of 58, which means that the share price of COSMOS Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 58% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 43, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 32, meaning the company has a riskier financing structure than 68% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 80% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 20. ...read more

more
Strongest Rank Refinancing
Weakest Rank Liquidity
Country Japan
Industry Drug Retail
Size Large
Website cosmospc.co.jp
Index
COSMOS Pharmaceutical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 11-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
58 31 23 17
Growth
43 69 51 75
Safety
Safety
32 55 69 67
Sentiment
20 91 49 45
360° View
360° View
13 79 42 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
30 57 29 29
Opinions Change
28 62 39 50
Pro Holdings
n/a 83 67 49
Market Pulse
11 71 75 65
Sentiment
20 91 49 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
58 31 23 17
Growth
43 69 51 75
Safety Safety
32 55 69 67
Combined
16 50 37 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
80 48 43 38
Price vs. Earnings (P/E)
78 41 27 29
Price vs. Book (P/B)
54 43 39 36
Dividend Yield
39 25 18 14
Value
58 31 23 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
55 70 70 65
Profit Growth
41 69 26 21
Capital Growth
63 48 44 55
Stock Returns
26 29 67 71
Growth
43 69 51 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
52 75 82 86
Refinancing
1 11 24 24
Liquidity
82 79 90 90
Safety Safety
32 55 69 67

Similar Stocks

Discover high‑ranked alternatives to COSMOS Pharmaceutical and broaden your portfolio horizons.

Omron

TYO:6645
Country: Japan
Industry: Electronic Components
Size: X-Large
Full Stock Analysis

Bridgestone

TYO:5108
Country: Japan
Industry: Tires & Rubber
Size: XX-Large
Full Stock Analysis

Tosoh

TYO:4042
Country: Japan
Industry: Commodity Chemicals
Size: X-Large
Full Stock Analysis

Mitsubishi Materials

TYO:5711
Country: Japan
Industry: Diversified Metals & Mining
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews